Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases
Author: Michael Kremer and Rachel Glennerster
Publisher: Princeton University Press
Publication date:
2004
Reviewer: Pierre Chirac
EN
Quote:
"Kremer and Glennerster's aim is to find practical ways to restart research and development for these 'neglected diseases' [conditions that predominantly affect poor people in developing countries]. They believe that market and public bodies have failed to motivate research and development — only one per cent of drugs launched onto the market during the past 25 years target such diseases. They are convinced that appropriate policies and public commitment could motivate private investment in this area."
Link to Nature book reviewReference:
Nature 431, 629 (2004)
Price: US$24.95, £15.95
Comments (1)
david makau
(
mt kenya university |
Kenya
)
16 February 2010
Its a good idea to come with a strategy that will reduce human trafficking due to poor health resulting from poor diets. But out of my research as a chemistry student from mt Kenya university (Kenya) the use of DDT as a pevention of mosquitoes has resulted to prolonged diseases mostly in Africa, this insectide contains dimethymercurate which is a very poisonous chemical when ingested in the human body, it causes brain damage leading to numberness,loss of vision and deafness. This is a common problem in southern Sudan where this chemical was dumped years ago. Its now our duty as researchers to come with ideas and strategies to save the in the southern Sudan. Kind regards
24 May 2013